$GTLB

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Ally Financial, GitLab, GLOBAL FOUNDRIES, Martin Marietta Materials, Rocket Lab USA, Strategy, Toast, Tower Semiconductor, and More

Major indices closed lower Tuesday due to war tensions and rising oil prices. The 30-year Treasury yield hit 5.27%, its highest since 2007, while Brent Crude surged 5% to $95. Analysts initiated coverage on Ally Financial (Strong Buy, $55 target) and GLOBAL FOUNDRIES (Buy, $60 target), among others.

Original reporting
Published Sep 2, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 1:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Ally Financial, GitLab, GLOBAL FOUNDRIES, Martin Marietta Materials, Rocket Lab USA, Strategy, Toast, Tower Semiconductor, and More — source image
Decision brief

The 30-second read

$GTLBBullishLow
01

Why it matters

While the rating changes provide fresh signals for the listed tickers, the overall market environment is negative, limiting immediate upside.

02

Market read

Provides new analyst viewpoints for a set of stocks, useful for short‑term positioning but constrained by broader market weakness.

03

What to watch

Potential macro risk from rising yields and oil price shock could dampen upside despite upgrades.

Relevance 5/10Novelty 4/10Timing: Wednesday

Background

The article compiles a list of analyst upgrades, downgrades, and initiations released on September 2, 2026, amid a broader market decline driven by war tensions and higher oil prices.

Company-level read

Ticker impact

$GTLBBullishMedium confidence
Context

Upgraded to Market Perform from Underperform by William Blair.

Expected impact

Small upside expected over next weeks.

Evidence & confidence

Upgrade signals improved perception, but no price target provided.

$IHGBullishMedium confidence
Context

Upgraded to Buy from Neutral by UBS with target raised to $188.

Expected impact

Potential rally toward $188.

Evidence & confidence

Buy rating and higher target suggest upside.

$MLMNeutralLow confidence
Context

Upgraded to Overweight from Neutral by JPMorgan, target unchanged at $680.

Expected impact

Sideways to modest upside.

Evidence & confidence

Target unchanged, upgrade reflects confidence but no new price level.

$OGEBullishMedium confidence
Context

Raised to Outperform from Sector Perform by RBC, target $54 from $50.

Expected impact

Potential upside toward $54.

Evidence & confidence

Target increase signals expected earnings improvement.

$SIRIBullishMedium confidence
Context

Upgraded to Buy from Hold by Deutsche Bank, target $45.

Expected impact

Possible rally toward $45.

Evidence & confidence

Buy rating and target provide clear upside.

$AMRZBearishMedium confidence
Context

Downgraded to Underperform from Neutral by BofA, target $52 from $57.

Expected impact

Potential decline toward $52.

Evidence & confidence

Lower target reflects weaker outlook.

$EYPTBearishHigh confidence
Context

Downgraded to Hold from Buy by TD Cowen, target cut to $4 from $20.

Expected impact

Likely drop toward $4.

Evidence & confidence

Large target reduction indicates serious concerns.

$KNFBearishMedium confidence
Context

Downgraded to Underweight from Neutral by JPMorgan, target $40 from $50.

Expected impact

Potential decline toward $40.

Evidence & confidence

Target cut reflects weaker expectations.

Market effects

Analyst rating changes may slightly shift sentiment in financial services, tech, and industrial sectors.

U.S. market sentiment modestly affected; no major regional shifts.

Limited global impact; primarily U.S.-focused equity analysts.

Counterpoint

Ratings upgrades may be premature given broader market weakness and macro headwinds.

Key entities

  • Raymond James

    Initiated Strong Buy on Ally Financial.

  • Stifel

    Initiated Buy ratings on GlobalFoundries and Tower Semiconductor.

Related articles

$RKLBMedAI 8/10

Why Rocket Lab Is Up Today

Rocket Lab shares rose 2% on defense awards, satellite work, and financing for its Iridium acquisition. The company secured $1.94B via share sale, replacing a $3.6B debt facility. It won $190M and $266M contracts from the U.S. government and Viasat. Raymond James initiated coverage with an $80 price target, expecting positive EBITDA and free cash flow by 2027-2028.

$RKLBMed

SpaceX Winds Down Falcon 9 As Rocket Lab Eyes Gap - Rocket Lab (NASDAQ:RKLB)

SpaceX (SPCX) is phasing out Falcon 9, focusing on Starship, and stopping new shared mission sales. Falcon 9's launch price rose 19% to $74M over five years. Rocket Lab (RKLB) sees an opportunity with its Neutron rocket, targeting 13-ton payloads. Rocket Lab's backlog exceeds 90 missions, and it aims to acquire Iridium (IRDM) for $8B, adding a satellite network. Neutron's 2026 launch probability is 9%, per Polymarket.

$RKLBHighAI 9/10

Rocket Lab's SpaceX Playbook: Own the Rocket, Constellation and Customer

Rocket Lab (RKLB) is expanding beyond rockets, acquiring Iridium (IRDM) for $8B to integrate launch, spacecraft, and services, similar to SpaceX's model. The deal adds Iridium's 66-satellite network and 2.5M subscribers. Rocket Lab aims to streamline operations and increase revenue, with Iridium generating $871.7M in 2025 vs. Rocket Lab's $602M. Key catalysts include FCC approval and Neutron's 2026 debut.

$MSTRMed

Strategy Swings From $10B Loss to $8B Profit as Bitcoin Hits $85K - Strategy (NASDAQ:MSTR)

Strategy (MSTR) reported an $8 billion unrealized profit after Bitcoin (BTC) surged to $85,000, reversing a previous $10 billion loss. The company acquired 950 BTC for $75.7 million, increasing its holdings to 846,000 BTC. MSTR's stock rose 48% in the past month, outperforming the Nasdaq-100. Technical analysis shows MSTR breaking above key resistance levels, but RSI is overbought.